⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL580718 | 0.75 | — | — | |
| SCHEMBL27696854 | 0.75 | — | — | |
| SCHEMBL27718563 | 0.75 | — | — | |
| SCHEMBL16382260 | 0.73 | KDM4E (0.54) | — | |
| SCHEMBL28190794 | 0.69 | KDM4E (0.48) | — | |
| SCHEMBL10622956 | 0.68 | — | — | |
| SCHEMBL980904 | 0.68 | — | — | |
| SCHEMBL5609721 | 0.67 | — | — | |
| SCHEMBL24534291 | 0.66 | CYP1A2 (0.54) | — | |
| SCHEMBL11985815 | 0.66 | MAPK1 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0393901-A1 | Ink composition | ADGER KOGYO CO., LTD. (JP) | 1990-10-24 | — | — | EP | claimed |
| CN-117924230-A | Heterocyclic compound and application thereof as thermal activation delayed fluorescence receptor unit | 中国石油化工股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-107846945-A | The purposes of composition, said composition comprising taste modulating compound and the food comprising said composition | 威·曼父子有限公司 | 2018-03-27 | — | — | CN | disclosed |
| US-9265767-B2 | 1,2-disubstituted heterocyclic compounds | FORUM PHARMACEUTICALS INC. (US) | 2016-02-23 | — | — | US | disclosed |
| US-20150274706-A1 | 1,2-DISUBSTITUTED HETEROCYCLIC COMPOUNDS | FMR LLC | 2015-10-01 | — | — | US | disclosed |
| US-8933074-B2 | 1,2-disubstituted heterocyclic compounds | FORUM PHARMACEUTICALS INC. (US) | 2015-01-13 | — | — | US | disclosed |
| US-20140011808-A1 | 1,2-DISUBSTITUTED HETEROCYCLIC COMPOUNDS | FMR LLC | 2014-01-09 | — | — | US | disclosed |
| US-8466148-B2 | 1,2-disubstituted heterocyclic compounds | ENVIVO PHARMACEUTICALS, INC. (US) | 2013-06-18 | — | — | US | disclosed |
| US-8071595-B2 | 1,2-disubstituted heterocyclic compounds | ENVIVO PHARMACEUTICALS, INC. (US) | 2011-12-06 | — | — | US | disclosed |
| US-20110171569-A1 | SULFONIUM DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | BASF SE (DE) | 2011-07-14 | — | — | US | disclosed |
| US-20110171569-A1 | SULFONIUM DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | BASF SE (DE) | 2011-07-14 | — | — | US | disclosed |
| US-20100167178-A1 | Oxime sulfonates and the use thereof as latent acids | YAMATO HITOSHI | 2010-07-01 | — | — | US | disclosed |
| US-20100167178-A1 | Oxime sulfonates and the use thereof as latent acids | YAMATO HITOSHI | 2010-07-01 | — | — | US | disclosed |
| WO-2009150074-A1 | SULFONIUM DERIVATIVES AND THE USE THEREOF AS LATENT ACIDS | BASF SE (DE) | 2009-12-17 | — | — | WO | disclosed |
| WO-2007147782-A2 | OXIME SULFONATES AND THE USE THEROF AS LATENT ACIDS | CIBA HOLDING INC. (CH) | 2007-12-27 | — | — | WO | disclosed |
| US-5082495-A | INK COMPOSITION | ADGER KOGYO CO., LTD. (JP) | 1992-01-21 | — | — | US | disclosed |
| EP-0393901-A1 | Ink composition | ADGER KOGYO CO., LTD. (JP) | 1990-10-24 | — | — | EP | disclosed |